Maintaining the high standards that made the previous editions such well-respected and
widely used references, Food Lipids: Chemistry, Nutrition, and Biotechnology, Fourth Edition …

Abstract Apolipoprotein C1 (apoC1) is a small size apolipoprotein whose exact role is not
totally clarified but which seems to modulate significantly the metabolism of lipoproteins …

In persons with dyslipidemia, a high residual risk of cardiovascular disease remains despite
lipid lowering therapy. Current cardiovascular risk prediction mainly focuses on low-density …

Background LDL‐cholesterol lowering variants that upregulate receptor uptake of LDL, such
as in PCSK9 and HMGCR, are associated with diabetes via unclear mechanisms. Activation …

Abstract Background Long non-coding RNAs (lncRNAs) can perform tasks of key relevance
in fat cells, contributing, when defective, to the burden of obesity and its sequelae. Here …

Results: Plasma IL-1β was near detection limit (0.071–0.216 pg ml− 1), while IL-1Ra
accumulated at 1000-folds higher (77–1068 pg ml− 1). Plasma apoB (0.34–1.80 gl− 1) …

Delayed clearance of triglyceride-rich lipoprotein (TRL) by white adipose tissue (WAT)
promotes hypertriglyceridemia and elevated apoB-lipoproteins, which are primarily in the …

Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) shuttles low-density
lipoprotein (LDL) receptors for degradation, thus upregulates LDL plasma clearance …

Background Elevated plasma apoB is an independent predictor of T2D; however, underlying
mechanisms remain unclear. Chronic reduction in white adipose tissue (WAT) function …

Background To optimize the prevention of type 2 diabetes (T2D), high-risk obese subjects
with the best metabolic recovery after a hypocaloric diet should be targeted. Apolipoprotein …